Sana Biotechnology, Inc. (SANA)
USD 1.69
(-11.78%)
USD 1.69
(-11.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -253.58 Million | -290.05 Million | -251.05 Million | -137.98 Million | -85.5 Million | -13.49 Million |
| Net Income | -283.25 Million | -269.47 Million | -355.92 Million | -285.3 Million | -130.77 Million | -13.24 Million |
| Depreciation & Amortization | 30.86 Million | 15.62 Million | 11.07 Million | 5.92 Million | 1.82 Million | 1000.00 |
| Deferred income taxes | -96.23 Million | - | - | - | -7.54 Million | - |
| Stock-based compensation | 35.53 Million | 38.33 Million | 22.36 Million | 5.82 Million | 1.49 Million | 118 Thousand |
| Change in working capital | 18.61 Million | 7.54 Million | 9.8 Million | 6.15 Million | 10.52 Million | -308 Thousand |
| Other non-cash items | 40.9 Million | -82.07 Million | 61.64 Million | 129.41 Million | 38.97 Million | -228 Thousand |
| Investing Cash Flow | 172.01 Million | 210.56 Million | -245.79 Million | -252.56 Million | -87.86 Million | -780 Thousand |
| Investments in PPE | -20.03 Million | -20.87 Million | -29.86 Million | -23.87 Million | -26.18 Million | -460 Thousand |
| Acquisitions | -192.04 Thousand | -231.43 Thousand | - | 228.69 Thousand | -3.19 Million | - |
| Investment purchases | -157.74 Million | -78.68 Million | -491.38 Million | -387.43 Million | -141.51 Million | - |
| Sales/Maturities of investments | 349.78 Million | 310.12 Million | 280.02 Million | 158.74 Million | 82.97 Million | - |
| Other Investing Activities | 192.04 Thousand | 231.43 Thousand | -4.57 Million | -228.69 Thousand | 59 Thousand | -320 Thousand |
| Financing Cash Flow | 31.64 Million | 4.91 Million | 631.75 Million | 435.68 Million | 223.72 Million | 45.72 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 31.64 Million | 4.91 Million | 631.75 Million | 149 Thousand | 1000.00 | 45.72 Million |
| Other Financing Activities | 31.64 Thousand | 4.91 Million | 631.75 Million | 435.53 Million | 223.72 Million | 91.44 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.02 Million | 1.05 Million | -266 Thousand | 1.98 Million | -421 Thousand | 289 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 17.58 Million | 6.48 Million | 10.06 Million | 4.17 Million | 10.94 Million | -597 Thousand |
| Cash at beginning of period | 182.86 Million | 261.84 Million | 126.94 Million | 81.8 Million | 31.44 Million | -816 Thousand |
| Cash at end of period | 137.34 Million | 187.27 Million | 261.84 Million | 126.94 Million | 81.8 Million | 30.63 Million |
| Capital Expenditure | -20.03 Million | -20.87 Million | -29.86 Million | -23.87 Million | -26.18 Million | -460 Thousand |
| Effect of forex changes on cash | 4.4 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -45.51 Million | -74.57 Million | 134.89 Million | 45.14 Million | 50.36 Million | 31.44 Million |
| Free Cash Flow | -273.61 Million | -310.92 Million | -280.91 Million | -161.85 Million | -111.68 Million | -13.95 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -50.29 Million | -107.47 Million | -88.11 Million | -283.25 Million | 984 Thousand | -113.99 Million |
| Depreciation & Amortization | 3.89 Million | 3.74 Million | 7.54 Million | 30.86 Million | 4.49 Million | 4.44 Million |
| Deferred income taxes | - | - | -24.34 Million | -96.23 Million | - | - |
| Stock-based compensation | 11.38 Million | 9.09 Million | 7.93 Million | 35.53 Million | 9 Million | 9.84 Million |
| Change in working capital | 2.34 Million | -7.46 Million | 10.24 Million | 18.61 Million | 5.17 Million | 13.99 Million |
| Other non-cash items | -7.37 Million | 54.11 Million | 34.79 Million | 40.9 Million | -83.21 Million | 26.9 Million |
| Investing Cash Flow | 5.81 Million | -77.22 Million | 15.31 Million | 172.01 Million | 51.34 Million | 42.62 Million |
| Investments in PPE | -13.05 Million | -15.84 Million | -14.04 Million | -20.03 Million | -2.23 Million | -1.57 Million |
| Acquisitions | - | - | -29.35 Thousand | -192.04 Thousand | -53.58 Thousand | -44.2 Thousand |
| Investment purchases | -62.62 Million | -114.39 Million | -26.12 Million | -157.74 Million | -60.35 Million | -50.83 Million |
| Sales/Maturities of investments | 81.49 Million | 53.01 Million | 55.48 Million | 349.78 Million | 113.93 Million | 95.04 Million |
| Other Investing Activities | - | -61.38 Million | 29.35 Thousand | 192.04 Thousand | 53.58 Thousand | 44.2 Thousand |
| Financing Cash Flow | 10.62 Million | 186.39 Million | 1.71 Million | 31.64 Million | 187 Thousand | 29.5 Million |
| Debt repayment | -7.62 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.99 Million | 186.39 Million | 1.71 Million | 31.64 Million | 187 Thousand | 29.5 Million |
| Other Financing Activities | 11.06 Million | 4.92 Million | 1718.00 | 31.64 Thousand | 187.00 | 29.5 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 667 Thousand | -1.06 Million | -1.33 Million | 1.02 Million | 2.27 Million | 441 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.68 Million | -6.39 Million | 11.58 Million | 17.58 Million | 2.9 Million | 13.55 Million |
| Cash at beginning of period | 180.88 Million | 137.34 Million | 172.28 Million | 182.86 Million | 184.29 Million | 170.96 Million |
| Cash at end of period | 138.79 Million | 180.88 Million | 137.34 Million | 137.34 Million | 172.28 Million | 184.29 Million |
| Capital Expenditure | -13.05 Million | -15.84 Million | -14.04 Million | -20.03 Million | -2.23 Million | -1.57 Million |
| Effect of forex changes on cash | - | - | - | 4.4 Million | - | - |
| Net cash flow / Change in cash | -42.09 Million | 43.53 Million | -34.93 Million | -45.51 Million | -12.01 Million | 13.33 Million |
| Free Cash Flow | -71.59 Million | -81.47 Million | -66 Million | -273.61 Million | -65.78 Million | -60.37 Million |
6242
MTA
DZSI
TRG
ZBH
LPDNF